INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Company

Phio Pharmaceuticals Corp.

Filed

June 18, 2025

Period of Report

June 6, 2025

Accession Number

0001062993-25-011890